Yael C Cohen

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including totale overleving ...

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS.